エピジェネティックに媒介された生物学的制御に関する反省と展望:癌と骨格病理学の妥協
Gary S Stein1,2
1Department of Biochemistry, Larner College of Medicine, University of Vermont, 89 Beaumont Avenue, Burlington, VT 05405, USA.
Academia biology
|August 21, 2025
まとめ
遺伝子発現を制御するエピジェネティックメカニズムは,DNAの配列を変えることなく, 細胞の発達,機能,そして病気に不可欠です. このヒストンのコードを理解することは 生物学的制御と病理学にとって不可欠です
科学分野:
- 分子生物学
- 遺伝学
- エピジェネティクス
背景:
- DNAと遺伝子コードは 遺伝子発現の理解の基礎をなしています
- ヒストンのコードを含む表遺伝的メカニズムは,DNAでコード化されていない経路を通じて遺伝子発現を制御する.
- これらのエピジェネティック要因は 生物学的活動と制御に不可欠です
研究 の 目的:
- 遺伝子発現におけるエピジェネティックメカニズムの補完的かつ義務的な役割を強調する.
- クロマチンの状態をサポートするヒストンコードの重要性を強調する.
- 発達,分化,生理学的反応に対する表遺伝的貢献の証拠をレビューする.
主な方法:
- エピジェネティックコントロールの累積証拠のレビュー
- 遺伝子発現におけるエピジェネティックパラメータの役割の分析
- 細胞および組織プロセスに対する表遺伝子学的貢献の検討.
主要な成果:
- 開発,差別化,生理学的反応性には 副遺伝的制御が不可欠である.
- エピジェネティックメカニズムは細胞の構造,機能,生存,組織修復をサポートします.
- 異常なエピジェネティック遺伝子発現は 腫瘍形成や骨格障害などの病気と関連しています
結論:
- エピジェネティックメカニズムは生物学的活動の必須決定因子です.
- ヒストンのコードはクロマチンの状態と遺伝子発現の重要なレギュラーです.
- エピジェネティック制御は,表型機能,腫瘍抑制,および疾患進行のバランスをとる決定的な要因です.
関連する概念動画
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Genomic Imprinting and Inheritance
35.2K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.2K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Spreading of Chromatin Modifications
8.5K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.5K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


